Aug 30 (Reuters) - CRISPR Therapeutics AG:
* CRISPR THERAPEUTICS AG - MAY OFFER AND SELL FROM TIME TO TIME ITS COMMON SHARES HAVING AGGREGATE OFFERING PRICE OF UP TO $200 MILLION
* CRISPR THERAPEUTICS AG SAYS ON AUGUST 30, CO ENTERED INTO AN OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC - SEC FILING Source: (bit.ly/2MKT4aM) Further company coverage: